Funding for this research was provided by:
Daewoong Pharmaceutical (No. 800-20140080)
Received: 17 May 2021
Accepted: 15 July 2021
First Online: 3 August 2021
: The procedures that involved the use of animals for the rat calvarial defect experiment were approved by the international animal care and use committee (SNUH IACUC No.13–0348).
: Not applicable.
: The authors declare that they have no competing interests.